Breast cancer (BC) can be divided into three major classes based on genetic and histological evidence: - Breast cancer displaying hormone receptors (estrogen receptor (ER+)) or progesterone receptor (PR+), - Breast cancer exhibiting human epidermal receptor 2 (HER2+), and - triple-negative breast cancer (TNBC). Here, ESR1 is linked to triple-negative breast carcinoma.